Dr Reddy's Laboratories Ltd (RDY)
68.26
-1.04
(-1.50%)
USD |
NYSE |
May 17, 16:00
68.26
0.00 (0.00%)
After-Hours: 20:00
Dr Reddy's Laboratories SG&A Expense (Quarterly): 386.27M for March 31, 2024
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 386.27M |
December 31, 2023 | 242.94M |
September 30, 2023 | 227.31M |
June 30, 2023 | 215.47M |
March 31, 2023 | 219.04M |
December 31, 2022 | 218.97M |
September 30, 2022 | 207.57M |
June 30, 2022 | 200.81M |
March 31, 2022 | 208.40M |
December 31, 2021 | 205.59M |
September 30, 2021 | 215.27M |
June 30, 2021 | 204.01M |
March 31, 2021 | 197.07M |
December 31, 2020 | 194.53M |
September 30, 2020 | 175.84M |
June 30, 2020 | 167.83M |
March 31, 2020 | 167.68M |
December 31, 2019 | 177.70M |
September 30, 2019 | 187.40M |
June 30, 2019 | 173.16M |
March 31, 2019 | 175.49M |
December 31, 2018 | 166.82M |
September 30, 2018 | 176.35M |
June 30, 2018 | 180.59M |
March 31, 2018 | 187.52M |
Date | Value |
---|---|
December 31, 2017 | 186.22M |
September 30, 2017 | 171.60M |
June 30, 2017 | 182.38M |
March 31, 2017 | 163.83M |
December 31, 2016 | 168.26M |
September 30, 2016 | 175.89M |
June 30, 2016 | 183.59M |
March 31, 2016 | 172.30M |
December 31, 2015 | 182.62M |
September 30, 2015 | 170.34M |
June 30, 2015 | 173.05M |
March 31, 2015 | 161.96M |
December 31, 2014 | 180.00M |
September 30, 2014 | 176.06M |
June 30, 2014 | 178.54M |
March 31, 2014 | 166.79M |
December 31, 2013 | 160.36M |
September 30, 2013 | 156.77M |
June 30, 2013 | 157.93M |
March 31, 2013 | 173.64M |
December 31, 2012 | 158.23M |
September 30, 2012 | 145.18M |
June 30, 2012 | 153.54M |
March 31, 2012 | 134.21M |
December 31, 2011 | 151.35M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
167.68M
Minimum
Mar 2020
386.27M
Maximum
Mar 2024
209.64M
Average
204.80M
Median
SG&A Expense (Quarterly) Benchmarks
Concord Medical Services Holdings Ltd | -- |
ASLAN Pharmaceuticals Ltd | 3.396M |
Zai Lab Ltd | 69.19M |
ICICI Bank Ltd | 595.96M |
SS Innovations International Inc | 1.224M |